Watson, Sun Seek Attorneys' Fees From Novartis
A federal judge on Friday agreed to allow Watson Pharmaceuticals Inc. and Sun Pharmaceutical Industries Ltd. to seek attorneys' fees in an infringement suit brought by Novartis Pharmaceuticals Corp. over patents...To view the full article, register now.
Already a subscriber? Click here to view full article